News / Events

 

HOA In the News!

New Radiation Therapy Technology At HOACNY Benefits Cancer Patients

Hematology/Oncology Associates of CNY (HOACNY) recently added a TrueBeam radiation therapy system to its cancer-fighting arsenal in its Brittonfield office in East Syracuse, completing its planned radiation technology upgrades.

Providing the most advanced linear accelerator and radiosurgery treatment system available, TrueBeam uses pinpoint accuracy to deliver higher doses of radiation in less time....

Check out the full article featured In Good Health

 

 

 

Partner Jeffrey L. Kirshner, MD Receives National Award for Contributions to Cancer Research

 Dr. KirshnerEast Syracuse, NY – At its national meeting this week in November, The Alliance for Clinical Trials in Oncology Foundation will recognize Jeffrey J. Kirshner, MD with the Richard L. Schilsky Cancer and Leukemia Group B Achievement (RLS CALGB) Award.Established in 2010, the honor is bestowed for significant contributions to cooperative group research for cancer care.

"With our mission to provide the highest level of care to patients, research is integral to identifying better and more effective therapies,” says Anthony J. Scalzo, MD, physician-partner and president of Hematology-Oncology Associates of CNY (HOACNY). “We are very thankful and proud that Dr. Kirshner has led the HOACNY research department for over 30 years.”

Scalzo further explained that Dr. Kirshner has consistently represented HOACNY with the American Society of Clinical Oncology (ASCO) and HOACNY’s main cooperative group, The Alliance for Clinical Trials in Oncology (The Alliance). “His leadership has been instrumental in our national recognition as a strong supporter and contributor to important cancer research,” Scalzo adds.

With The Alliance, Dr. Kirshner serves as Chair of the Alliance Data and Safety Monitoring Board and is a member of the Alliance Breast Committee, Alliance Symptom Intervention Committee, and Alliance Community Oncology Committee. He serves on several committees for ASCO, including CancerLinQ Research and Publications. He is a member of the Practice Guidelines Implementation Network (PGIN) and serves as the community oncology representative on four expert panels. Dr. Kirshner also has authored or co-authored more than 70 peer-reviewed research publications. 

Clinical Trials at HOACNY

“Before, clinical trials were sometimes seen only as a “last resort” when people had no other treatment options,” explains Kirshner. “However, many people with early stage cancers choose to participate in treatment and/or symptom management clinical trials, making today’s clinical trials tomorrow’s standard of care!”

Kirshner explained that patients should ask their physician and other members of their healthcare team about clinical trial options for them, as well as check the NCI website cancer.gov. Additionally, HOACNY also offers individuals the option to contact its Research Department at 315-472-7504 (x1350). 

HOACNY joined The Cancer and Leukemia Group B in 1983 which merged with two other cooperative groups becoming the Alliance in 2014, when the NCI discontinued its Community Clinical Oncology Program. This partnership continues to allow HOACNY to offer patients research opportunities utilizing state-of-the-art cancer treatments with access to many of the same clinical trials typically available at large cancer treatment centers. That is possible because The Alliance is part of the National Clinical Trials Network NCTN) sponsored by the National Cancer Institute (NCI) and a research base for the NCI Community Research Oncology Program (NCORP). HOACNY also participates in clinical trials sponsored by private industry and pharmaceutical companies.

 

 

The Savior In My Own Backyard

https://eaglenewsonline.com/new/2020/10/08/hoacny-the-savior-in-my-own-backyard/

 

 

Dr. Alpert and Cyberknife in the News!

HOA Cyberknife In the News

Being able to safely deliver higher radiation dose means less treatments.

Check out the video!

 

 

 

 

With deepest regret HOA will be canceling Surviors Day 2020.  

At HOA, our top priority is the health and wellness of our patients, families, staff and community. As the COVID-19 pandemic evolves, we have made a very tough decision to cancel HOA Survivors Day 2020, which will include both our Auburn June 7th and Liverpool Long Branch Park event  May 31st.

If you have purchased a remembrance plant already, we can refund you or apply this to our event in June 2021. If you would like a refund, please contact Marianne Hatch at 315-472-7504 ext.: 1367. If we do not hear from you, we will apply your request for a plant to 2021 event.

Thank you for your understanding during this difficult time as we all work through this together.

 

 

HOA's CyberKinfe in the News!

There is a great article regarding our CyberKnife by Eagle News Online.  After 10 years of impressive clinical outcomes, remarkable pain relief and new hope for cancer patients, Hematology-Oncology Associates of Central New York (HOA) recently replaced their original CyberKnife with an updated, even more precise, faster and effective version known as the CyberKnife M6 Series. ...more here.

 

The Conversation with Dr. Tony Scalzo

Carrie Lazarus sits down with one of the area's leading cancer specialists, Dr. Tony Scalzo. Dr. Scalzo says melanoma has increased 10-fold in the last two decades.

 

 Three Main Lessons of Leadership and How to Use Them

 Maryann Roefaro

Three Main Lessons of Leadership and How to Use Them – were recently explained to syracuse.com by our CEO, Maryann Roefaro, author of “Building the Team from the Inside Out.” read more here...

 

 

 

 

 

 Dr. Anthony Scalzo explains

Colon cancers risks, prevention measures and screening guidelines, plus the importance of talking with your primary care provider.

 Dr. Anthony Scalzo explains colon cancers risks

 

 Stay current with our Patient Newsletter and press releases about what’s happening at HOA.